We are live on ! Find out more
ENTL

Entellus Medical, Inc. Common Stock
ENTL

Delisted

ENTL was delisted on the 27th of February, 2018.

55 hedge funds and large institutions have $228M invested in Entellus Medical, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 31 increasing their positions, 11 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 11

4% more capital invested

Capital invested by funds: $220M → $228M (+$8.02M)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

2% less funds holding

Funds holding: 5655 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
55
Holders Change
-1
Holders Change %
-1.79%
% of All Funds
1.47%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
3
Increased
31
Reduced
11
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$5.28K +$4.98K +289 New
Creative Planning
52
Creative Planning
Kansas
$4K
LTFS
53
Ladenburg Thalmann Financial Services
Florida
$4K
Morgan Stanley
54
Morgan Stanley
New York
$3K -$37.6K -2,181 -94%
MTIP
55
Magee Thomson Investment Partners
California
$1K -$3.84K -223 -77%
Adage Capital Partners
56
Adage Capital Partners
Massachusetts
-$3.64M -200,000 Closed
GIP
57
Granite Investment Partners
California
-$1.07M -58,963 Closed
Citigroup
58
Citigroup
New York
-$70K -3,823 Closed
Barclays
59
Barclays
United Kingdom
-$13K -700 Closed

ENTL Hedge Fund Activity: Q2 2016 in Review

55 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Entellus Medical, Inc. Common Stock (ENTL) for Q2 2016, worth a combined $228M — up 3.6% from $220M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ENTL and 3 opened new positions — a net loss of 1 holder — while 11 trimmed existing stakes and 31 added.

The largest buyer was Michael R. Murphy, adding an estimated $2.5M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $3.64M sold.

  • 55 institutional investors held Entellus Medical, Inc. Common Stock (ENTL) as of Q2 2016, down from 56 in Q1 2016.
  • Funds reported $228M of Entellus Medical, Inc. Common Stock stock for Q2 2016, up 3.6% quarter-over-quarter.
  • 3 funds opened new Entellus Medical, Inc. Common Stock positions in Q2 2016 and 4 closed out, a net change of -1 holder.
  • The largest Entellus Medical, Inc. Common Stock buyer in Q2 2016 was Michael R. Murphy, an estimated $2.5M added.
  • The largest Entellus Medical, Inc. Common Stock seller in Q2 2016 was Adage Capital Partners, an estimated $3.64M sold.

Based on aggregated 13F filings for Q2 2016.